4.6 Review

mTOR complex 2 signaling and functions

Journal

CELL CYCLE
Volume 10, Issue 14, Pages 2305-2316

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/cc.10.14.16586

Keywords

mTOR; mTORC2; rictor; cancer; metabolism; ribosomes; protein synthesis; protein maturation; AGC kinases; growth factor signaling

Categories

Funding

  1. National Institutes of Health [GM079176]
  2. American Cancer Society [RSG0721601TBE]
  3. Cancer Research Institute

Ask authors/readers for more resources

The mechanistic target of rapamycin (mTOR) plays a central role in cellular growth and metabolism. mTOR forms two distinct protein complexes, mTORC1 and mTORC2. Much is known on the regulation and functions of mTORC1 due to availability of a natural compound, rapamycin, that inhibits this complex. Studies that define mTORC2 cellular functions and signaling have lagged behind. The development of pharmacological inhibitors that block mTOR kinase activity, and thereby inhibit both mTOR complexes, along with availability of mice with genetic knockouts in mTOR complex components have now provided new insights on mTORC2 function and regulation. Since prolonged effects of rapamycin can also disrupt mTORC2, it is worth to re-evaluate the contribution of this less-studied mTOR complex in cancer, metabolic disorders and aging. In this review, we focus on recent developments on mammalian mTORC2 signaling mechanisms and its cellular and tissue-specific functions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available